Table 2. . Association of tumor infiltrating lymphocytes intensity, distribution and perivascular state with clinical features.
Features | Total n = 39† | p-value | Diffuse, n = 15 (%) | Total n = 39‡ | p-value | Total n = 40§ | p-value | |||
---|---|---|---|---|---|---|---|---|---|---|
Mild, n = 28 (%) | Moderate + marked, n = 11 (%) | Focal, n = 9 (%) | Multifocal, n = 15 (%) | Absent, n = 31 (%) | Mild + definite, n = 9 (%) | |||||
Age (years) | 0.060 | 0.097 | 0.451 | |||||||
Median (range) | 53 (98–74) | 44 (21–68) | 53 (36–73) | 37 (13–74) | 46 (8–72) | 51 (8–74) | 47 (37–73) | |||
<48 | 11 (57.9) | 8 (42.1) | 4 (21.1) | 6 (31.6) | 9 (47.4) | 14 (70.0) | 6 (30.0) | |||
≥ 48 | 17 (85.0) | 3 (15.0) | 11 (55.0) | 3 (15.0) | 6 (30.0) | 17 (85.0) | 3 (15.0) | |||
Gender | 0.798 | 0.002 | 1.000 | |||||||
Female | 14 (73.7) | 5 (26.3) | 10 (52.6) | 7 (36.8) | 2 (10.5) | 16 (80.0) | 4 (20.0) | |||
Male | 14 (70.0) | 6 (30.0) | 5 (25.0) | 2 (10.0) | 13 (65.0) | 15 (75.0) | 5 (25.0) | |||
Karnofsky | 1.000 | 1.000 | 0.453 | |||||||
≤ 80 | 10 (71.4) | 4 (28.6) | 6 (42.9) | 3 (21.4) | 5 (35.7) | 12 (85.7) | 2 (14.3) | |||
>80 | 18 (72.0) | 7 (28.0) | 9 (36.0) | 6 (24.0) | 10 (40.0) | 19 (73.1) | 7 (26.9) | |||
Resection | 0.648 | 0.773 | 0.457 | |||||||
Subtotal | 13 (68.4) | 6 (31.6) | 8 (42.1) | 5 (26.3) | 6 (31.6) | 16 (84.2) | 3 (15.8) | |||
Total | 15 (75.0) | 5 (25.0) | 7 (35.0) | 4 (20.0) | 9 (45.0) | 15 (71.4) | 6 (28.6) | |||
Promotor MGMT | 0.406 | 0.775 | 0.236 | |||||||
1 | 13 (81.2) | 3 (18.8) | 7 (43.8) | 3 (18.8) | 6 (37.5) | 13 (81.2) | 3 (18.8) | |||
2/3 | 8 (61.5) | 5 (38.5) | 6 (46.2) | 1 (7.7) | 6 (46.2) | 8 (57.1) | 6 (42.9) | |||
Tumor size (cm) | 0.956 | 0.916 | 0.133 | |||||||
Median (range) | 5 (2–7) | 5.1 (3–7) | 5 (3.3–7) | 4 (2–5.3) | 5 (3.2–7) | 4.7 (2–7) | 5.9 (3.3–6.3) | |||
<5 cm | 13 (72.2) | 5 (27.8) | 6 (33.3) | 5 (27.8) | 7 (38.9) | 17 (89.5) | 2 (10.5) | |||
≥ 5 cm | 15 (71.4) | 6 (28.6) | 9 (42.9) | 4 (19.0) | 8 (38.1) | 14 (66.7) | 7 (33.3) |
†Four cases do not specify TIL intensity category.
‡Four cases do not specify TIL distribution category.
§Three cases do not specify perivascular state.
TIL: Tumor-infiltrating lymphocyte.